Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

SPECT imaging

  • Preclinical Evaluation of <sup>226</sup>Ac as a Theranostic Agent: Imaging, Dosimetry, and Therapy
    You have access
    Preclinical Evaluation of 226Ac as a Theranostic Agent: Imaging, Dosimetry, and Therapy
    Helena Koniar, Luke Wharton, Aidan Ingham, Ana Paulina Morales Oliver, Helen Merkens, Cristina Rodríguez-Rodríguez, Peter Kunz, Valery Radchenko, Hua Yang, Arman Rahmim, Carlos Uribe and Paul Schaffer
    Journal of Nuclear Medicine November 1, 2024, 65 (11) 1762-1768; DOI: https://doi.org/10.2967/jnumed.124.267999
  • Open Access
    Molecular Imaging, Radiochemistry, and Environmental Pollutants
    Samantha Delaney, Joni Sebastiano, Brian M. Zeglis and Outi M. Keinänen
    Journal of Nuclear Medicine August 1, 2023, 64 (8) 1179-1184; DOI: https://doi.org/10.2967/jnumed.122.265209
  • You have access
    A Phase 1 and Biodistribution Study of ABT-806i, an 111In-Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806
    Hui K. Gan, Matthew Burge, Benjamin Solomon, Sze Ting Lee, Kyle D. Holen, Yumin Zhang, Marika Ciprotti, F.T. Lee, Wijith Munasinghe, JuDee Fischer, Peter Ansell, Gerard Fox, Hao Xiong, Edward B. Reilly, Rod Humerickhouse and Andrew M. Scott
    Journal of Nuclear Medicine June 1, 2021, 62 (6) 787-794; DOI: https://doi.org/10.2967/jnumed.120.253146
  • Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer
    Open Access
    Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer
    Julia Baguña Torres, Michael Mosley, Sofia Koustoulidou, Samantha Hopkins, Stefan Knapp, Apirat Chaikuad, Masuo Kondoh, Keisuke Tachibana, Veerle Kersemans and Bart Cornelissen
    Journal of Nuclear Medicine December 1, 2020, 61 (12) 1756-1763; DOI: https://doi.org/10.2967/jnumed.120.243113
  • You have access
    Noninvasive Whole-Body Imaging of Phosphatidylethanolamine as a Cell Death Marker Using 99mTc-Duramycin During TNF-Induced SIRS
    Tinneke Delvaeye, Leonie wyffels, Steven Deleye, Kelly Lemeire, Amanda Gonçalves, Elke Decrock, Steven Staelens, Luc Leybaert, Peter Vandenabeele and Dmitri V. Krysko
    Journal of Nuclear Medicine July 1, 2018, 59 (7) 1140-1145; DOI: https://doi.org/10.2967/jnumed.117.205815
  • You have access
    Early Prediction of Tumor Response to Treatment: Preclinical Validation of 99mTc-Duramycin
    Filipe Elvas, Christel Vangestel, Koon Pak, Peter Vermeulen, Brian Gray, Sigrid Stroobants, Steven Staelens and Leonie Wyffels
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 805-811; DOI: https://doi.org/10.2967/jnumed.115.168344
  • You have access
    Immuno-PET and Immuno-SPECT of Rheumatoid Arthritis with Radiolabeled Anti–Fibroblast Activation Protein Antibody Correlates with Severity of Arthritis
    Peter Laverman, Tessa van der Geest, Samantha Y.A. Terry, Danny Gerrits, Birgitte Walgreen, Monique M. Helsen, Tapan K. Nayak, Anne Freimoser-Grundschober, Inja Waldhauer, Ralf J. Hosse, Ekkehard Moessner, Pablo Umana, Christian Klein, Wim J.G. Oyen, Marije I. Koenders and Otto C. Boerman
    Journal of Nuclear Medicine May 1, 2015, 56 (5) 778-783; DOI: https://doi.org/10.2967/jnumed.114.152959
  • You have access
    123I-Iododexetimide Preferentially Binds to the Muscarinic Receptor Subtype M1 In Vivo
    Geor Bakker, Wilhelmina A. Vingerhoets, Jan–Peter van Wieringen, Kora de Bruin, Jos Eersels, Jan de Jong, Youssef Chahid, Bart P. Rutten, Susan DuBois, Megan Watson, Adrian J. Mogg, Hongling Xiao, Michael Crabtree, David A. Collier, Christian C. Felder, Vanessa N. Barth, Lisa M. Broad, Oswald J. Bloemen, Thérèse A. van Amelsvoort and Jan Booij
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 317-322; DOI: https://doi.org/10.2967/jnumed.114.147488
  • You have access
    Glial Activation in the Early Stages of Brain Metastasis: TSPO as a Diagnostic Biomarker
    Emma R. O’Brien, Veerle Kersemans, Matthew Tredwell, Begona Checa, Sébastien Serres, Manuel Sarmiento Soto, Veronique Gouverneur, David Leppert, Daniel C. Anthony and Nicola R. Sibson
    Journal of Nuclear Medicine February 1, 2014, 55 (2) 275-280; DOI: https://doi.org/10.2967/jnumed.113.127449
  • You have access
    Imaging Integrin αvβ3 on Blood Vessels with 111In-RGD2 in Head and Neck Tumor Xenografts
    Samantha Y.A. Terry, Keelara Abiraj, Cathelijne Frielink, Laura K. van Dijk, Johan Bussink, Wim J. Oyen and Otto C. Boerman
    Journal of Nuclear Medicine February 1, 2014, 55 (2) 281-286; DOI: https://doi.org/10.2967/jnumed.113.129668
SNMMI

© 2025 SNMMI

Powered by HighWire